Amarin





Ebit Veränderung Datum
AbbVie USD 5.81B 4.36B 2025-12
Alnylam Pharmaceuticals USD -29.96M 34.85M 2025-09
Amarin USD -1.7M 8.47M 2025-09
AstraZeneca USD 2.97B 4.48B 2025-12
BioCryst Pharmaceuticals USD -4.51M 12.2M 2024-12
DBV Technologies USD -34.28M 6.83M 2025-09
Esperion Therapeutics USD -16.03M 11.51M 2024-09
GlaxoSmithKline GBP 1.44B 1.35B 2025-12
Halozyme Therapeutics USD 217.92M 15.48M 2025-09
Heron Therapeutics USD -4.46M 5.76M 2024-09
Ionis Pharmaceuticals USD -160.18M 304.96M 2025-09
Nektar Therapeutics USD -34.34M 3.68M 2024-09
Neurocrine Biosciences USD 239.3M 93.7M 2025-09
Novartis USD -9.19B 13.87B 2025-06


Amarin - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Feb 2026.